Figure 2From: Potential new therapeutic modality revealed through agent-based modeling of the neuromuscular junction and acetylcholinesterase inhibitionModel validation with active and GB inhibited AChE at two GB:AChE ratios (1, 2). Rates of ACh turnover are consistent with published values (A) and inhibition elongates the e.p.p. (B). Legend refers to both A and B.Back to article page